ANK1

ankyrin 1, the group of Ankyrin repeat domain containing|MicroRNA protein coding host genes

Basic information

Region (hg38): 8:41653220-41896741

Previous symbols: [ "ANK" ]

Links

ENSG00000029534NCBI:286OMIM:612641HGNC:492Uniprot:P16157AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hereditary spherocytosis type 1 (Strong), mode of inheritance: AD
  • hereditary spherocytosis (Supportive), mode of inheritance: AD
  • hereditary spherocytosis type 1 (Strong), mode of inheritance: AD
  • hereditary spherocytosis type 1 (Limited), mode of inheritance: AR
  • hereditary spherocytosis (Limited), mode of inheritance: AR
  • hereditary spherocytosis (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spherocytosis, type 1AD/ARHematologicSome individuals may have therapy requiring neonatal hyperbilirubinemia, as well as severe, transfusion-requiring anemiaHematologic14467968; 4476391; 2675425; 1832935; 1486040; 8640229; 9887280; 9430667; 17327413; 20512576; 32436265

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANK1 gene.

  • Hereditary spherocytosis type 1 (64 variants)
  • not provided (57 variants)
  • ANK1-related disorder (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANK1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
27
clinvar
103
clinvar
10
clinvar
140
missense
1
clinvar
2
clinvar
308
clinvar
11
clinvar
2
clinvar
324
nonsense
47
clinvar
34
clinvar
81
start loss
1
clinvar
1
frameshift
53
clinvar
81
clinvar
3
clinvar
137
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
12
clinvar
39
clinvar
2
clinvar
53
splice region
16
11
2
29
non coding
1
clinvar
2
clinvar
62
clinvar
37
clinvar
87
clinvar
189
Total 114 159 404 151 99

Highest pathogenic variant AF is 0.00000657

Variants in ANK1

This is a list of pathogenic ClinVar variants found in the ANK1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-41653381-G-A Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 13, 2018)909496
8-41653448-G-C Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)362951
8-41653509-G-A Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)362952
8-41653518-G-C Uncertain significance (Jan 15, 2021)1163482
8-41653618-G-T Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 12, 2018)362953
8-41653638-A-C Hereditary spherocytosis type 1 • Spherocytosis Benign (Jan 13, 2018)362954
8-41653667-C-A Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 12, 2018)362955
8-41653768-C-T Hereditary spherocytosis type 1 • Spherocytosis Benign/Likely benign (Jan 13, 2018)362956
8-41653838-C-T Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 12, 2018)362957
8-41653891-C-T Hereditary spherocytosis type 1 • Spherocytosis Benign/Likely benign (Jan 12, 2018)362958
8-41653898-C-A Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)908703
8-41653898-C-T Spherocytosis • Hereditary spherocytosis type 1 Conflicting classifications of pathogenicity (Jan 13, 2018)908704
8-41653906-C-T Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)908705
8-41653910-G-T Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)908706
8-41653932-T-G Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)909559
8-41653982-T-C Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)909560
8-41654082-C-G Hereditary spherocytosis type 1 • Spherocytosis Conflicting classifications of pathogenicity (Apr 01, 2023)362959
8-41654123-A-T Hereditary spherocytosis type 1 Likely benign (Apr 27, 2017)362960
8-41654181-G-C Hereditary spherocytosis type 1 • Spherocytosis Benign/Likely benign (Jan 13, 2018)362961
8-41654187-G-C Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)910487
8-41654200-C-T Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)362962
8-41654316-G-A Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)910488
8-41654366-G-A Spherocytosis • Hereditary spherocytosis type 1 Uncertain significance (Jan 12, 2018)911718
8-41654378-C-T Hereditary spherocytosis type 1 • Spherocytosis Uncertain significance (Jan 13, 2018)911719
8-41654388-C-A Hereditary spherocytosis type 1 • Spherocytosis Conflicting classifications of pathogenicity (Jan 12, 2018)362963

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANK1protein_codingprotein_codingENST00000265709 43243542
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.004.23e-912558401641257480.000652
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.089271.12e+30.8250.000076412316
Missense in Polyphen354506.30.699195445
Synonymous-0.6485024841.040.00003613884
Loss of Function8.06992.80.09700.000005051064

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.003070.00298
Ashkenazi Jewish0.0002990.000298
East Asian0.0004380.000435
Finnish0.001210.00120
European (Non-Finnish)0.0006120.000607
Middle Eastern0.0004380.000435
South Asian0.000.00
Other0.001150.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646}.;
Disease
DISEASE: Spherocytosis 1 (SPH1) [MIM:182900]: A form of spherocytosis, a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. SPH1 is characterized by severe hemolytic anemia. Inheritance can be autosomal dominant or autosomal recessive. Patients with homozygous mutations have a more severe disorder. {ECO:0000269|PubMed:11102985, ECO:0000269|PubMed:8640229}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Proteoglycans in cancer - Homo sapiens (human);Developmental Biology;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;NrCAM interactions;CHL1 interactions;Neurofascin interactions;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Interaction between L1 and Ankyrins;L1CAM interactions;COPI-mediated anterograde transport;Axon guidance;ER to Golgi Anterograde Transport (Consensus)

Recessive Scores

pRec
0.748

Intolerance Scores

loftool
0.109
rvis_EVS
-3.14
rvis_percentile_EVS
0.45

Haploinsufficiency Scores

pHI
0.753
hipred
Y
hipred_score
0.825
ghis
0.547

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.968

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ank1
Phenotype
liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; renal/urinary system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
exocytosis;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;signal transduction;positive regulation of organelle organization;maintenance of epithelial cell apical/basal polarity;protein localization to plasma membrane
Cellular component
nucleus;cytosol;cytoskeleton;plasma membrane;cytoplasmic side of plasma membrane;spectrin-associated cytoskeleton;membrane;basolateral plasma membrane;sarcoplasmic reticulum;Z disc;axolemma;M band;sarcolemma;axon initial segment;postsynaptic membrane
Molecular function
structural molecule activity;structural constituent of cytoskeleton;protein binding;cytoskeletal adaptor activity;enzyme binding;protein phosphatase binding;spectrin binding;ion channel binding;ATPase binding